GCI-α-synuclein is 1000-fold more potent than LB-α-synuclein in seeding the aggregation of monomeric α-synuclein, which may explain the highly aggressive and rapidly progressive nature of MSA symptoms. This evidence concerns the gene SNCA and multiple system atrophy.